Status:
RECRUITING
Oral Dydrogesterone as Luteal Phase Support in Natural Cycle FET
Lead Sponsor:
The University of Hong Kong
Conditions:
Subfertility
Eligibility:
FEMALE
18-42 years
Phase:
PHASE3
Brief Summary
This randomised double-blinded controlled trial aims to compare the live birth rate in natural FET cycles with and without oral dydrogesterone as luteal phase support. The hypothesis is that the use o...
Detailed Description
Trial design: Women undergoing FET in the Centre of Assisted Reproduction and Embryology, The University of Hong Kong-Queen Mary Hospital, will be recruited and will be randomized into one of the fol...
Eligibility Criteria
Inclusion
- Age of women \<43 years at the time of stimulated IVF
- Replacing early cleavage embryos or blastocysts after thawing
Exclusion
- Requiring hormonal replacement cycles
- Use of donor oocytes or embryos
- Undergoing preimplantation genetic testing
- Presence of hydrosalpinx not corrected surgically prior to FET
- Refusal to join the study
Key Trial Info
Start Date :
July 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2026
Estimated Enrollment :
716 Patients enrolled
Trial Details
Trial ID
NCT03859921
Start Date
July 1 2021
End Date
November 30 2026
Last Update
June 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Obstetrics and Gynaecology
Hong Kong, Hong Kong, China